done independently by 3 persons. The call and error rates are shown in Table 1 . Despite the suboptimal amount of input gDNA, the best call and error rates were nearly optimal. The most common errors, results indicating that heterozygous individuals were homozygous, were attributable to allele dropouts most probably due to an insufficient amount or low quality of template gDNA. Details of sample flow and call and error rates for each individual gene can be seen in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/ content/vol53/issue5.
When extraction of proteins from disks was performed before extraction of DNA, the resulting wgaDNA generally showed higher TaqMan genotype call rates and lower error rates than wgaDNA from disks that had not undergone pre-extraction of proteins (Table 1 ). This result suggests that the pre-extraction procedure removes compounds from the filter paper disks that may interfere with the WGA reaction. This explanation is in accordance with the observation that the use of 2 disks that had not undergone protein pre-extraction gave inferior results than did the use of only 1 disk, whereas the opposite was the case for the preextracted disks, for which the use of 2 disks instead of 1 yielded superior results ( Table 1 ). The DBSS used in this study were stored for only a limited time, and we do not know the effect on the quality of wgaDNA of prolonged storage at room temperature or at Ϫ20°C.
Our results demonstrate that DBSS disks previously used for multiplex protein measurements are reliable sources of gDNA that is suitable for WGA and SNP genotyping. The study also shows that both the Omniplex-based method producing short wgaDNA of 400 -500 bp and the multiple-displacement amplification-based method producing long wgaDNA of 10 -20 kbp are well suited for the amplification. In our setup, the amount of template gDNA from each extraction was sufficient for ϳ20 amplifications, and the yield of wgaDNA from 1 amplification was enough for ϳ300 TaqMan genotypings. In a family affected by hypergonadotropic ovarian failure, a mutation in the pro-region of the BMP15 gene (Y235C) was found in 2 affected sisters (1 ), and 3 linked markers within the BMP15 gene (Ϫ673CϾT, Ϫ9CϾG and IVS1 ϩ 905AϾG) are associated with high follicle production in women undergoing recombinant FSH stimulation (2 ) .
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Several heterozygous variations affecting the pro-region and mature peptide of the BMP15 gene have been identified in women with POF (3-5 ), but A180T was the only variant found in all reported studies, occurring with relatively high frequency in POF women (8 of 502, 1.6%) but not at all in control groups.
To clarify the role of the A180T allele in early menopause and ovarian failure, we used a pyrosequencing protocol (Biotage) to evaluate the A180T variant. This technology allows an easy 96-well typing format. The selected primers for pyrose- Pre-extracted disks were subjected to protein extraction prior to DNA extraction.
quencing analysis and PCR conditions were forward: 5Ј-ACC GCC ATC ATC TCC AAC TAA-3Ј, reverse: 5Ј-biotine-CCT GTG TCC CTT GTT ATT CCA-3Ј, and sequencing: 5Ј-AAC CTT CCC TGA TGT CT-3Ј. We used reextraction and conventional resequencing of a random set of samples (10%) with the CEQ Dye Terminator Cycle Sequencing Quick Start Kit (Beckman) to assure the quality of our genotyping protocol (see Figure 1 in the Data Supplement that accompanies the online version of this letter at http://www.clinchem.org/ content/vol53/issue4). We investigated the presence of the A180T allele and also reproductive, gynecological, and other important traits in 1157 white Spanish postmenopausal women divided into 3 clinical groups. Group A included women whose age at natural menopause was in the normal range (Ն40 years, n ϭ 852), group B included women with secondary amenorrhea (SA; age at natural menopause Ͻ40 years, n ϭ 46), and group C included women with menopause induced by surgery for treatment of benign or malignant gynecological pathologies (n ϭ 249). The observed mean (SD) ages at menopause and menarche [48.4 (5.0) and 12.9 (1.56) years, respectively] were strictly concordant with others previously reported. Written informed consent was obtained from all study participants, and the study protocol was approved by the referral center Ethics Committees and Neocodex.
Genotyping revealed the A180T variant only in 7 unrelated individuals, suggesting a variant allele frequency of 0.3% in the Spanish population. The clinical data and related morbidity of the 7 women who were heterozygous carriers of A180T variant are reported in Table 1 . Among these women, 1 patient had menopause caused by a surgical intervention for endometriosis (group C). Only 1 patient displayed the SA phenotype (group B). The other 5 women had proven fertility and a natural menopause occurring at Ͼ40 years (group A).
To analyze relevant variables involved in age at menopause, such as age at menarche, reproductive period, pregnancies, and body mass index, we further studied patients with a natural menopause (n ϭ 898) by dividing them into 2 genotypic groups (presence/absence of A180T variant). Our results indicated that the groups did not differ in any clinical variable studied (P Ͼ0.13). Nevertheless, women carrying the A180T variant seemed to have a lower mean (SD) age at menopause Research to date has detected the A180T variant in only 10 women. Of these, 5 of 166 were Italian women with POF (3 ); 1 of 133 and 2 of 60 Indian women with POF or primary amenorrhea, respectively (4 ); and 2 of 203 European women with POF (5 ). Furthermore, no control individuals analyzed to date have been carriers the A180T allele (n ϭ 462, merged sample size). In contrast with these observations, we detected the A180T allele in 5 women with natural menopause occurring at Ͼ40 years of age. Our results indicate that the A180T allele is a rare variant that is not sufficient to generate SA in humans. That the allele has not been found in control groups to date does not exclude the possible presence of this rare variant in unaffected individuals, because the number of controls used in studies to date may have been insufficient to detect very low frequency alleles. However, our data also support the finding that genetic variation in the BMP15 gene may contribute to variation in age at menopause in a complex manner, but this interpretation should be viewed with caution.
To elucidate the role of BMP15 in ovulation rate, POF, and SA, exhaustive analysis of this gene in independent large populations would be required. 
